![]() Ac-Asp-Glu-Val-Asp-chloromethylketone trifluoroacetate salt structure
|
Common Name | Ac-Asp-Glu-Val-Asp-chloromethylketone trifluoroacetate salt | ||
---|---|---|---|---|
CAS Number | 285570-60-7 | Molecular Weight | 550.944 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 1048.1±65.0 °C at 760 mmHg | |
Molecular Formula | C21H31ClN4O11 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 587.7±34.3 °C |
Use of Ac-Asp-Glu-Val-Asp-chloromethylketone trifluoroacetate saltAc-DEVD-CMK (Caspase-3 Inhibitor III) is a selective and irreversible caspase-3 inhibitor. Ac-DEVD-CMK significantly inhibits apoptosis induced by high levels of glucose or 3,20-dibenzoate (IDB; HY-137295). Ac-DEVD-CMK can be used in a variety of experimental approaches to inhibit apoptosis[1][2][3]. |
Name | Ac-DEVD-CMK |
---|---|
Synonym | More Synonyms |
Description | Ac-DEVD-CMK (Caspase-3 Inhibitor III) is a selective and irreversible caspase-3 inhibitor. Ac-DEVD-CMK significantly inhibits apoptosis induced by high levels of glucose or 3,20-dibenzoate (IDB; HY-137295). Ac-DEVD-CMK can be used in a variety of experimental approaches to inhibit apoptosis[1][2][3]. |
---|---|
Related Catalog | |
Target |
Caspase-3 |
In Vitro | Ac-DEVD-CMK (100 μM; 24 小时) 抑制 IDB 诱导的细胞凋亡[3]。 Apoptosis Analysis[3] Cell Line: Jurkat cells Concentration: 100 μM Incubation Time: 24 h Result: Inhibited ingenol IDB (10 μM)-induced apoptosis. |
In Vivo | Ac-DEVD-CMK (Caspase-3 Inhibitor III; 25 mg/kg; 腹腔给药; 单剂量; APAP 后 3 小时) 显着减弱对乙酰氨基酚 (APAP; HY-66005) 诱导的肝损伤 (AILI)[4]。 Animal Model: 6- to 8-week-old females and males Sdc1-/- mice[4] Dosage: 25 mg/kg Administration: IP; single dose; 3 hours post-APAP Result: Significantly attenuated APAP (ip; 500 or 625 mg/kg)-induced liver injury (AILI), indicating that inhibition of GSK-3β or caspase-3 activity mitigates liver damage. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 1048.1±65.0 °C at 760 mmHg |
Molecular Formula | C21H31ClN4O11 |
Molecular Weight | 550.944 |
Flash Point | 587.7±34.3 °C |
Exact Mass | 550.167786 |
PSA | 245.37000 |
LogP | 0.41 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.539 |
L-Valinamide, N-acetyl-L-α-aspartyl-L-α-glutamyl-N-[(1S)-1-(carboxymethyl)-3-chloro-2-oxopropyl]- |
N-Acetyl-L-α-aspartyl-L-α-glutamyl-N-[(2S)-1-carboxy-4-chloro-3-oxo-2-butanyl]-L-valinamide |